Samsung Bioepis Submits a Biosimilar Candidate, to the European Medicines Agency
Samsung Bioepis announced their submission to the to the European Medicines Agency (EMA) for SB2, its Remicade…
14/03/2015 - 2 minutes
News and Trends
Get prepared: Pi day is coming!
Pi day, the unofficial annual holiday commemorating the math constant π, has this year a…
13/03/2015 - 2 minutes
Orgenesis acquires MaSTherCell
Orgenesis acquired MaSTherCell, an emerging pioneer in the industrialization of cell-based therapeutics based in Gosselies,…
13/03/2015 - 2 minutes
Alderley Park Life Science Campus, on the go
Manchester Science Partnerships (MSP) and Bruntwood have revealed plans for the first phase of development…
12/03/2015 - 2 minutes
Bioluminescent Bacteria and Algae, the Future Lighting
The University of Sevilla has patented a method for culturing the bacteria Vibrio fischeri and…
12/03/2015 - 2 minutes
Sanofi and its Succesful Pivot from Chemistry to Biotechnology [BIO-Spring 2015]
Sanofi is France's largest pharma company and the 3rd biggest in the World. The VIP guest…
12/03/2015 - 4 minutes
First Treatment Approved under Early Access to Medicine Scheme (EAMS)
Today, it has been accepted! The first drug approved through the Early Access to Medicine Scheme…
11/03/2015 - 2 minutes
Vitic database, the new must-have tool
The latest version of the Vitic Intermediates database, chemical database and information management system, has been…
11/03/2015 - 3 minutes
The Promising Company OSE Pharma launches an IPO
Created in 2012 by Emile Loria and Dominique Costantini, OSE Pharma is a European cancer…
10/03/2015 - 3 minutes
350th anniversary of Philosophical Transactions, the first scientific journal
The world’s oldest continuously published journal, Philosophical Transactions of the Royal Society of London (RSL),…
10/03/2015 - 3 minutes
Live from Bio-Europe 2015: The product development challenges in the gene therapy field
Gene Therapy is really the hot topic right now in the field of Biotech especially with…
10/03/2015 - 3 minutes
MorphoSys and Emergent BioSolutions Initiate Phase I
MorphoSys AG and Emergent BioSolutions will initiate a Phase I clinical study to evaluate the…
09/03/2015 - 3 minutes
